Request for Covid-19 Impact Assessment of this Report
The United States Brucella Abortus Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Brucella Abortus Vaccine market, reaching US$ million by the year 2028. As for the Europe Brucella Abortus Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Brucella Abortus Vaccine players cover Zoetis, CEVA, Merck Animal Health, and Biovet, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Brucella Abortus Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
DNA Vaccines
Subunit Vaccines
Vector Vaccines
B. Abortus Recombinant Mutants
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Cattles
Sheep
Pigs
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Zoetis
CEVA
Merck Animal Health
Biovet
CAVAC
JOVAC
Merial
Colorado Serum Company
VECOL
Tecnovax
Indian Immunologicals
Vetal
Dollvet
Centro Diagnostico Veterinario
Onderstepoort Biological Products
Institute of Animal Health and Veterinary Biologicals
Biogenesis Bago
Instituto Rosenbusch
SYVA Laboratorios
CZ Veterinaria
Hester Biosciences
Qilu Animal Health
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Brucella Abortus Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Brucella Abortus Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Brucella Abortus Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Brucella Abortus Vaccine Segment by Type
2.2.1 DNA Vaccines
2.2.2 Subunit Vaccines
2.2.3 Vector Vaccines
2.2.4 B. Abortus Recombinant Mutants
2.2.5 Others
2.3 Brucella Abortus Vaccine Sales by Type
2.3.1 Global Brucella Abortus Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Brucella Abortus Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Brucella Abortus Vaccine Sale Price by Type (2017-2022)
2.4 Brucella Abortus Vaccine Segment by Application
2.4.1 Cattles
2.4.2 Sheep
2.4.3 Pigs
2.4.4 Others
2.5 Brucella Abortus Vaccine Sales by Application
2.5.1 Global Brucella Abortus Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Brucella Abortus Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Brucella Abortus Vaccine Sale Price by Application (2017-2022)
3 Global Brucella Abortus Vaccine by Company
3.1 Global Brucella Abortus Vaccine Breakdown Data by Company
3.1.1 Global Brucella Abortus Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Brucella Abortus Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Brucella Abortus Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Brucella Abortus Vaccine Revenue by Company (2020-2022)
3.2.2 Global Brucella Abortus Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Brucella Abortus Vaccine Sale Price by Company
3.4 Key Manufacturers Brucella Abortus Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Brucella Abortus Vaccine Product Location Distribution
3.4.2 Players Brucella Abortus Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Brucella Abortus Vaccine by Geographic Region
4.1 World Historic Brucella Abortus Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Brucella Abortus Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Brucella Abortus Vaccine Annual Revenue by Geographic Region
4.2 World Historic Brucella Abortus Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Brucella Abortus Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Brucella Abortus Vaccine Annual Revenue by Country/Region
4.3 Americas Brucella Abortus Vaccine Sales Growth
4.4 APAC Brucella Abortus Vaccine Sales Growth
4.5 Europe Brucella Abortus Vaccine Sales Growth
4.6 Middle East & Africa Brucella Abortus Vaccine Sales Growth
5 Americas
5.1 Americas Brucella Abortus Vaccine Sales by Country
5.1.1 Americas Brucella Abortus Vaccine Sales by Country (2017-2022)
5.1.2 Americas Brucella Abortus Vaccine Revenue by Country (2017-2022)
5.2 Americas Brucella Abortus Vaccine Sales by Type
5.3 Americas Brucella Abortus Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Brucella Abortus Vaccine Sales by Region
6.1.1 APAC Brucella Abortus Vaccine Sales by Region (2017-2022)
6.1.2 APAC Brucella Abortus Vaccine Revenue by Region (2017-2022)
6.2 APAC Brucella Abortus Vaccine Sales by Type
6.3 APAC Brucella Abortus Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Brucella Abortus Vaccine by Country
7.1.1 Europe Brucella Abortus Vaccine Sales by Country (2017-2022)
7.1.2 Europe Brucella Abortus Vaccine Revenue by Country (2017-2022)
7.2 Europe Brucella Abortus Vaccine Sales by Type
7.3 Europe Brucella Abortus Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Brucella Abortus Vaccine by Country
8.1.1 Middle East & Africa Brucella Abortus Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Brucella Abortus Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Brucella Abortus Vaccine Sales by Type
8.3 Middle East & Africa Brucella Abortus Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Brucella Abortus Vaccine
10.3 Manufacturing Process Analysis of Brucella Abortus Vaccine
10.4 Industry Chain Structure of Brucella Abortus Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Brucella Abortus Vaccine Distributors
11.3 Brucella Abortus Vaccine Customer
12 World Forecast Review for Brucella Abortus Vaccine by Geographic Region
12.1 Global Brucella Abortus Vaccine Market Size Forecast by Region
12.1.1 Global Brucella Abortus Vaccine Forecast by Region (2023-2028)
12.1.2 Global Brucella Abortus Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Brucella Abortus Vaccine Forecast by Type
12.7 Global Brucella Abortus Vaccine Forecast by Application
13 Key Players Analysis
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Brucella Abortus Vaccine Product Offered
13.1.3 Zoetis Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 CEVA
13.2.1 CEVA Company Information
13.2.2 CEVA Brucella Abortus Vaccine Product Offered
13.2.3 CEVA Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 CEVA Main Business Overview
13.2.5 CEVA Latest Developments
13.3 Merck Animal Health
13.3.1 Merck Animal Health Company Information
13.3.2 Merck Animal Health Brucella Abortus Vaccine Product Offered
13.3.3 Merck Animal Health Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Merck Animal Health Main Business Overview
13.3.5 Merck Animal Health Latest Developments
13.4 Biovet
13.4.1 Biovet Company Information
13.4.2 Biovet Brucella Abortus Vaccine Product Offered
13.4.3 Biovet Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Biovet Main Business Overview
13.4.5 Biovet Latest Developments
13.5 CAVAC
13.5.1 CAVAC Company Information
13.5.2 CAVAC Brucella Abortus Vaccine Product Offered
13.5.3 CAVAC Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 CAVAC Main Business Overview
13.5.5 CAVAC Latest Developments
13.6 JOVAC
13.6.1 JOVAC Company Information
13.6.2 JOVAC Brucella Abortus Vaccine Product Offered
13.6.3 JOVAC Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 JOVAC Main Business Overview
13.6.5 JOVAC Latest Developments
13.7 Merial
13.7.1 Merial Company Information
13.7.2 Merial Brucella Abortus Vaccine Product Offered
13.7.3 Merial Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Merial Main Business Overview
13.7.5 Merial Latest Developments
13.8 Colorado Serum Company
13.8.1 Colorado Serum Company Company Information
13.8.2 Colorado Serum Company Brucella Abortus Vaccine Product Offered
13.8.3 Colorado Serum Company Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Colorado Serum Company Main Business Overview
13.8.5 Colorado Serum Company Latest Developments
13.9 VECOL
13.9.1 VECOL Company Information
13.9.2 VECOL Brucella Abortus Vaccine Product Offered
13.9.3 VECOL Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 VECOL Main Business Overview
13.9.5 VECOL Latest Developments
13.10 Tecnovax
13.10.1 Tecnovax Company Information
13.10.2 Tecnovax Brucella Abortus Vaccine Product Offered
13.10.3 Tecnovax Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Tecnovax Main Business Overview
13.10.5 Tecnovax Latest Developments
13.11 Indian Immunologicals
13.11.1 Indian Immunologicals Company Information
13.11.2 Indian Immunologicals Brucella Abortus Vaccine Product Offered
13.11.3 Indian Immunologicals Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Indian Immunologicals Main Business Overview
13.11.5 Indian Immunologicals Latest Developments
13.12 Vetal
13.12.1 Vetal Company Information
13.12.2 Vetal Brucella Abortus Vaccine Product Offered
13.12.3 Vetal Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Vetal Main Business Overview
13.12.5 Vetal Latest Developments
13.13 Dollvet
13.13.1 Dollvet Company Information
13.13.2 Dollvet Brucella Abortus Vaccine Product Offered
13.13.3 Dollvet Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Dollvet Main Business Overview
13.13.5 Dollvet Latest Developments
13.14 Centro Diagnostico Veterinario
13.14.1 Centro Diagnostico Veterinario Company Information
13.14.2 Centro Diagnostico Veterinario Brucella Abortus Vaccine Product Offered
13.14.3 Centro Diagnostico Veterinario Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Centro Diagnostico Veterinario Main Business Overview
13.14.5 Centro Diagnostico Veterinario Latest Developments
13.15 Onderstepoort Biological Products
13.15.1 Onderstepoort Biological Products Company Information
13.15.2 Onderstepoort Biological Products Brucella Abortus Vaccine Product Offered
13.15.3 Onderstepoort Biological Products Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Onderstepoort Biological Products Main Business Overview
13.15.5 Onderstepoort Biological Products Latest Developments
13.16 Institute of Animal Health and Veterinary Biologicals
13.16.1 Institute of Animal Health and Veterinary Biologicals Company Information
13.16.2 Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Product Offered
13.16.3 Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Institute of Animal Health and Veterinary Biologicals Main Business Overview
13.16.5 Institute of Animal Health and Veterinary Biologicals Latest Developments
13.17 Biogenesis Bago
13.17.1 Biogenesis Bago Company Information
13.17.2 Biogenesis Bago Brucella Abortus Vaccine Product Offered
13.17.3 Biogenesis Bago Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Biogenesis Bago Main Business Overview
13.17.5 Biogenesis Bago Latest Developments
13.18 Instituto Rosenbusch
13.18.1 Instituto Rosenbusch Company Information
13.18.2 Instituto Rosenbusch Brucella Abortus Vaccine Product Offered
13.18.3 Instituto Rosenbusch Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Instituto Rosenbusch Main Business Overview
13.18.5 Instituto Rosenbusch Latest Developments
13.19 SYVA Laboratorios
13.19.1 SYVA Laboratorios Company Information
13.19.2 SYVA Laboratorios Brucella Abortus Vaccine Product Offered
13.19.3 SYVA Laboratorios Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 SYVA Laboratorios Main Business Overview
13.19.5 SYVA Laboratorios Latest Developments
13.20 CZ Veterinaria
13.20.1 CZ Veterinaria Company Information
13.20.2 CZ Veterinaria Brucella Abortus Vaccine Product Offered
13.20.3 CZ Veterinaria Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 CZ Veterinaria Main Business Overview
13.20.5 CZ Veterinaria Latest Developments
13.21 Hester Biosciences
13.21.1 Hester Biosciences Company Information
13.21.2 Hester Biosciences Brucella Abortus Vaccine Product Offered
13.21.3 Hester Biosciences Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.21.4 Hester Biosciences Main Business Overview
13.21.5 Hester Biosciences Latest Developments
13.22 Qilu Animal Health
13.22.1 Qilu Animal Health Company Information
13.22.2 Qilu Animal Health Brucella Abortus Vaccine Product Offered
13.22.3 Qilu Animal Health Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.22.4 Qilu Animal Health Main Business Overview
13.22.5 Qilu Animal Health Latest Developments
14 Research Findings and Conclusion
Table 1. Brucella Abortus Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Brucella Abortus Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of DNA Vaccines
Table 4. Major Players of Subunit Vaccines
Table 5. Major Players of Vector Vaccines
Table 6. Major Players of B. Abortus Recombinant Mutants
Table 7. Major Players of Others
Table 8. Global Brucella Abortus Vaccine Sales by Type (2017-2022) & (K Units)
Table 9. Global Brucella Abortus Vaccine Sales Market Share by Type (2017-2022)
Table 10. Global Brucella Abortus Vaccine Revenue by Type (2017-2022) & ($ million)
Table 11. Global Brucella Abortus Vaccine Revenue Market Share by Type (2017-2022)
Table 12. Global Brucella Abortus Vaccine Sale Price by Type (2017-2022) & (USD/Unit)
Table 13. Global Brucella Abortus Vaccine Sales by Application (2017-2022) & (K Units)
Table 14. Global Brucella Abortus Vaccine Sales Market Share by Application (2017-2022)
Table 15. Global Brucella Abortus Vaccine Revenue by Application (2017-2022)
Table 16. Global Brucella Abortus Vaccine Revenue Market Share by Application (2017-2022)
Table 17. Global Brucella Abortus Vaccine Sale Price by Application (2017-2022) & (USD/Unit)
Table 18. Global Brucella Abortus Vaccine Sales by Company (2020-2022) & (K Units)
Table 19. Global Brucella Abortus Vaccine Sales Market Share by Company (2020-2022)
Table 20. Global Brucella Abortus Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Brucella Abortus Vaccine Revenue Market Share by Company (2020-2022)
Table 22. Global Brucella Abortus Vaccine Sale Price by Company (2020-2022) & (USD/Unit)
Table 23. Key Manufacturers Brucella Abortus Vaccine Producing Area Distribution and Sales Area
Table 24. Players Brucella Abortus Vaccine Products Offered
Table 25. Brucella Abortus Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Brucella Abortus Vaccine Sales by Geographic Region (2017-2022) & (K Units)
Table 29. Global Brucella Abortus Vaccine Sales Market Share Geographic Region (2017-2022)
Table 30. Global Brucella Abortus Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Brucella Abortus Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Brucella Abortus Vaccine Sales by Country/Region (2017-2022) & (K Units)
Table 33. Global Brucella Abortus Vaccine Sales Market Share by Country/Region (2017-2022)
Table 34. Global Brucella Abortus Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Brucella Abortus Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Brucella Abortus Vaccine Sales by Country (2017-2022) & (K Units)
Table 37. Americas Brucella Abortus Vaccine Sales Market Share by Country (2017-2022)
Table 38. Americas Brucella Abortus Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Brucella Abortus Vaccine Revenue Market Share by Country (2017-2022)
Table 40. Americas Brucella Abortus Vaccine Sales by Type (2017-2022) & (K Units)
Table 41. Americas Brucella Abortus Vaccine Sales Market Share by Type (2017-2022)
Table 42. Americas Brucella Abortus Vaccine Sales by Application (2017-2022) & (K Units)
Table 43. Americas Brucella Abortus Vaccine Sales Market Share by Application (2017-2022)
Table 44. APAC Brucella Abortus Vaccine Sales by Region (2017-2022) & (K Units)
Table 45. APAC Brucella Abortus Vaccine Sales Market Share by Region (2017-2022)
Table 46. APAC Brucella Abortus Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Brucella Abortus Vaccine Revenue Market Share by Region (2017-2022)
Table 48. APAC Brucella Abortus Vaccine Sales by Type (2017-2022) & (K Units)
Table 49. APAC Brucella Abortus Vaccine Sales Market Share by Type (2017-2022)
Table 50. APAC Brucella Abortus Vaccine Sales by Application (2017-2022) & (K Units)
Table 51. APAC Brucella Abortus Vaccine Sales Market Share by Application (2017-2022)
Table 52. Europe Brucella Abortus Vaccine Sales by Country (2017-2022) & (K Units)
Table 53. Europe Brucella Abortus Vaccine Sales Market Share by Country (2017-2022)
Table 54. Europe Brucella Abortus Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Brucella Abortus Vaccine Revenue Market Share by Country (2017-2022)
Table 56. Europe Brucella Abortus Vaccine Sales by Type (2017-2022) & (K Units)
Table 57. Europe Brucella Abortus Vaccine Sales Market Share by Type (2017-2022)
Table 58. Europe Brucella Abortus Vaccine Sales by Application (2017-2022) & (K Units)
Table 59. Europe Brucella Abortus Vaccine Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Brucella Abortus Vaccine Sales by Country (2017-2022) & (K Units)
Table 61. Middle East & Africa Brucella Abortus Vaccine Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Brucella Abortus Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Brucella Abortus Vaccine Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Brucella Abortus Vaccine Sales by Type (2017-2022) & (K Units)
Table 65. Middle East & Africa Brucella Abortus Vaccine Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Brucella Abortus Vaccine Sales by Application (2017-2022) & (K Units)
Table 67. Middle East & Africa Brucella Abortus Vaccine Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Brucella Abortus Vaccine
Table 69. Key Market Challenges & Risks of Brucella Abortus Vaccine
Table 70. Key Industry Trends of Brucella Abortus Vaccine
Table 71. Brucella Abortus Vaccine Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Brucella Abortus Vaccine Distributors List
Table 74. Brucella Abortus Vaccine Customer List
Table 75. Global Brucella Abortus Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 76. Global Brucella Abortus Vaccine Sales Market Forecast by Region
Table 77. Global Brucella Abortus Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Brucella Abortus Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Brucella Abortus Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 80. Americas Brucella Abortus Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Brucella Abortus Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 82. APAC Brucella Abortus Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Brucella Abortus Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Europe Brucella Abortus Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Brucella Abortus Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 86. Middle East & Africa Brucella Abortus Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Brucella Abortus Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 88. Global Brucella Abortus Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Brucella Abortus Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Brucella Abortus Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Brucella Abortus Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 92. Global Brucella Abortus Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Brucella Abortus Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Brucella Abortus Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 95. Zoetis Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 96. Zoetis Brucella Abortus Vaccine Product Offered
Table 97. Zoetis Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 98. Zoetis Main Business
Table 99. Zoetis Latest Developments
Table 100. CEVA Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 101. CEVA Brucella Abortus Vaccine Product Offered
Table 102. CEVA Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 103. CEVA Main Business
Table 104. CEVA Latest Developments
Table 105. Merck Animal Health Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 106. Merck Animal Health Brucella Abortus Vaccine Product Offered
Table 107. Merck Animal Health Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 108. Merck Animal Health Main Business
Table 109. Merck Animal Health Latest Developments
Table 110. Biovet Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 111. Biovet Brucella Abortus Vaccine Product Offered
Table 112. Biovet Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 113. Biovet Main Business
Table 114. Biovet Latest Developments
Table 115. CAVAC Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 116. CAVAC Brucella Abortus Vaccine Product Offered
Table 117. CAVAC Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 118. CAVAC Main Business
Table 119. CAVAC Latest Developments
Table 120. JOVAC Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 121. JOVAC Brucella Abortus Vaccine Product Offered
Table 122. JOVAC Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 123. JOVAC Main Business
Table 124. JOVAC Latest Developments
Table 125. Merial Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 126. Merial Brucella Abortus Vaccine Product Offered
Table 127. Merial Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 128. Merial Main Business
Table 129. Merial Latest Developments
Table 130. Colorado Serum Company Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 131. Colorado Serum Company Brucella Abortus Vaccine Product Offered
Table 132. Colorado Serum Company Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 133. Colorado Serum Company Main Business
Table 134. Colorado Serum Company Latest Developments
Table 135. VECOL Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 136. VECOL Brucella Abortus Vaccine Product Offered
Table 137. VECOL Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 138. VECOL Main Business
Table 139. VECOL Latest Developments
Table 140. Tecnovax Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 141. Tecnovax Brucella Abortus Vaccine Product Offered
Table 142. Tecnovax Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 143. Tecnovax Main Business
Table 144. Tecnovax Latest Developments
Table 145. Indian Immunologicals Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 146. Indian Immunologicals Brucella Abortus Vaccine Product Offered
Table 147. Indian Immunologicals Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 148. Indian Immunologicals Main Business
Table 149. Indian Immunologicals Latest Developments
Table 150. Vetal Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 151. Vetal Brucella Abortus Vaccine Product Offered
Table 152. Vetal Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 153. Vetal Main Business
Table 154. Vetal Latest Developments
Table 155. Dollvet Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 156. Dollvet Brucella Abortus Vaccine Product Offered
Table 157. Dollvet Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 158. Dollvet Main Business
Table 159. Dollvet Latest Developments
Table 160. Centro Diagnostico Veterinario Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 161. Centro Diagnostico Veterinario Brucella Abortus Vaccine Product Offered
Table 162. Centro Diagnostico Veterinario Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 163. Centro Diagnostico Veterinario Main Business
Table 164. Centro Diagnostico Veterinario Latest Developments
Table 165. Onderstepoort Biological Products Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 166. Onderstepoort Biological Products Brucella Abortus Vaccine Product Offered
Table 167. Onderstepoort Biological Products Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 168. Onderstepoort Biological Products Main Business
Table 169. Onderstepoort Biological Products Latest Developments
Table 170. Institute of Animal Health and Veterinary Biologicals Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 171. Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Product Offered
Table 172. Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 173. Institute of Animal Health and Veterinary Biologicals Main Business
Table 174. Institute of Animal Health and Veterinary Biologicals Latest Developments
Table 175. Biogenesis Bago Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 176. Biogenesis Bago Brucella Abortus Vaccine Product Offered
Table 177. Biogenesis Bago Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 178. Biogenesis Bago Main Business
Table 179. Biogenesis Bago Latest Developments
Table 180. Instituto Rosenbusch Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 181. Instituto Rosenbusch Brucella Abortus Vaccine Product Offered
Table 182. Instituto Rosenbusch Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 183. Instituto Rosenbusch Main Business
Table 184. Instituto Rosenbusch Latest Developments
Table 185. SYVA Laboratorios Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 186. SYVA Laboratorios Brucella Abortus Vaccine Product Offered
Table 187. SYVA Laboratorios Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 188. SYVA Laboratorios Main Business
Table 189. SYVA Laboratorios Latest Developments
Table 190. CZ Veterinaria Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 191. CZ Veterinaria Brucella Abortus Vaccine Product Offered
Table 192. CZ Veterinaria Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 193. CZ Veterinaria Main Business
Table 194. CZ Veterinaria Latest Developments
Table 195. Hester Biosciences Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 196. Hester Biosciences Brucella Abortus Vaccine Product Offered
Table 197. Hester Biosciences Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 198. Hester Biosciences Main Business
Table 199. Hester Biosciences Latest Developments
Table 200. Qilu Animal Health Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 201. Qilu Animal Health Brucella Abortus Vaccine Product Offered
Table 202. Qilu Animal Health Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 203. Qilu Animal Health Main Business
Table 204. Qilu Animal Health Latest Developments
List of Figures
Figure 1. Picture of Brucella Abortus Vaccine
Figure 2. Brucella Abortus Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Brucella Abortus Vaccine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Brucella Abortus Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Brucella Abortus Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of DNA Vaccines
Figure 10. Product Picture of Subunit Vaccines
Figure 11. Product Picture of Vector Vaccines
Figure 12. Product Picture of B. Abortus Recombinant Mutants
Figure 13. Product Picture of Others
Figure 14. Global Brucella Abortus Vaccine Sales Market Share by Type in 2021
Figure 15. Global Brucella Abortus Vaccine Revenue Market Share by Type (2017-2022)
Figure 16. Brucella Abortus Vaccine Consumed in Cattles
Figure 17. Global Brucella Abortus Vaccine Market: Cattles (2017-2022) & (K Units)
Figure 18. Brucella Abortus Vaccine Consumed in Sheep
Figure 19. Global Brucella Abortus Vaccine Market: Sheep (2017-2022) & (K Units)
Figure 20. Brucella Abortus Vaccine Consumed in Pigs
Figure 21. Global Brucella Abortus Vaccine Market: Pigs (2017-2022) & (K Units)
Figure 22. Brucella Abortus Vaccine Consumed in Others
Figure 23. Global Brucella Abortus Vaccine Market: Others (2017-2022) & (K Units)
Figure 24. Global Brucella Abortus Vaccine Sales Market Share by Application (2017-2022)
Figure 25. Global Brucella Abortus Vaccine Revenue Market Share by Application in 2021
Figure 26. Brucella Abortus Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Brucella Abortus Vaccine Revenue Market Share by Company in 2021
Figure 28. Global Brucella Abortus Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Brucella Abortus Vaccine Revenue Market Share by Geographic Region in 2021
Figure 30. Global Brucella Abortus Vaccine Sales Market Share by Region (2017-2022)
Figure 31. Global Brucella Abortus Vaccine Revenue Market Share by Country/Region in 2021
Figure 32. Americas Brucella Abortus Vaccine Sales 2017-2022 (K Units)
Figure 33. Americas Brucella Abortus Vaccine Revenue 2017-2022 ($ Millions)
Figure 34. APAC Brucella Abortus Vaccine Sales 2017-2022 (K Units)
Figure 35. APAC Brucella Abortus Vaccine Revenue 2017-2022 ($ Millions)
Figure 36. Europe Brucella Abortus Vaccine Sales 2017-2022 (K Units)
Figure 37. Europe Brucella Abortus Vaccine Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Brucella Abortus Vaccine Sales 2017-2022 (K Units)
Figure 39. Middle East & Africa Brucella Abortus Vaccine Revenue 2017-2022 ($ Millions)
Figure 40. Americas Brucella Abortus Vaccine Sales Market Share by Country in 2021
Figure 41. Americas Brucella Abortus Vaccine Revenue Market Share by Country in 2021
Figure 42. United States Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Brucella Abortus Vaccine Sales Market Share by Region in 2021
Figure 47. APAC Brucella Abortus Vaccine Revenue Market Share by Regions in 2021
Figure 48. China Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Brucella Abortus Vaccine Sales Market Share by Country in 2021
Figure 55. Europe Brucella Abortus Vaccine Revenue Market Share by Country in 2021
Figure 56. Germany Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Brucella Abortus Vaccine Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Brucella Abortus Vaccine Revenue Market Share by Country in 2021
Figure 63. Egypt Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Brucella Abortus Vaccine in 2021
Figure 69. Manufacturing Process Analysis of Brucella Abortus Vaccine
Figure 70. Industry Chain Structure of Brucella Abortus Vaccine
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...